KENDRA WATTS: Open Payments
NPI 1114428034 · WILKESBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$595 in 31 payments from 12 companies in 2025. Trend: 2023 $700 · 2024 $724 · 2025 $595
Food & beverage: $595
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $101 |
| GlaxoSmithKline, LLC. | 4 | $78 |
| Novo Nordisk Inc | 4 | $69 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $68 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Axsome Therapeutics, Inc. | 2 | $57 |
| ABBVIE INC. | 3 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Viatris Specialty LLC | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
Products named: TRELEGY ELLIPTA, Ozempic, Kerendia, REXULTI, Auvelity, AIRSUPRA, CAPLYTA, BREZTRI.
Industry payments across NC — which companies pay providers there.
